CSI Market
Sign In | Register

Burning Rock Biotech Limited (BNR) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access BNR Annual Cash Flow →
A period-by-period view of cash flow from Burning Rock Biotech Limited to Dec 31 2024 helps clarify how Dec 31 2025's cash position has changed over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		0 0 0 (Dec 31 2024)
Operating Activities
Income-7.92
Depreciation & amortization3.09
Amortization of Other Assets0.02
Increase (Decrease) in Deferred Revenue-1.44
Impairment of Long-Lived Assets to be Disposed of0.00
Provision For Loan Losses Expensed1.91
Inventories Decrease /-Increase-0.36
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.03
Share-based Compensation1.98
Income (Loss) from Equity Method Investments0.00
Foreign Currency Transaction Gain (Loss), Unrealized-0.96
Allowance For Contract Assets-
Increase Decrease In Contract With Customer Asset-
Increase Decrease In Prepayments And Other Current Assets-
Increase Decrease In Accrued Liabilities And Other Current Liabilities-
Increase Decrease In Contract With Customer Liability-
Allowance For Credit Losses-
Change In Fair Value Of Convertible Note Receivable-
Non Cashoperating Lease Expenses-
Derecognition Of Right Of Use Assets And Lease Liability-
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable4.43
Increase (Decrease) in Accounts Payable, Trade1.03
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Prepaid Expense and Other Assets0.00
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-3.27
Discontinued operations0.00
Net Cash flow from Operating Activities-4.07
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.12
Proceeds from Sale, Maturity and Collection of Short-term Investments0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Prepayment Of Property And Equipment-
Prepayment Of Property Equipment And Intangible Assets-
Restricted Cash and Investments Increase (Decrease)0.00
Payments to Acquire Loans Receivable0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-0.63
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.29
Long-term debt - repayments0.01
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-0.17
Proceeds From Ipo And Concurrent Private Placement Cpp Net Of Issuance Costs-
Proceeds From Issuance Of Convertible Preferred Shares And Warrant-
Finance Lease Principal Payments-
Payments For Purchase Of Treasury Stock-
Purchase Of Property And Equipment Included In Accounts Payable-
Purchase Of Property And Equipment Included In Capital Lease Obligations-
Non Cash Financial Or Equity Instrument Extinguishment Of Warrant Liability Through Exercise Of Warrant-
Conversion Of Convertible Notes Into Series C Convertible Preferred Shares-
Financing Lease Obligations Payments-
Refund Of Consideration For Employee Share Incentive Program-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities0.27
Effect of exchange rate on cash flow-1.45
Discontinued operations0.00
Free Cash Flow-3.94
Total Cash Flow-5.87
4 historic quarters locked

Sign in to unlock the full Burning Rock Biotech Limited cash flow history.

Sign In Create Free Account

About Burning Rock Biotech Ltd Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 20-F filings and normalized by CSIMarket.

Source & verification

  • Form: 20-F (Period: 20251231)
  • Filed with the SEC: April 28, 2026
  • Source: d31568d20f.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001193125-26-183377

Figures are derived from filed reports and may be restated. Historical data is subject to revision.